Pratt Collard Advisory Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$2.93M Buy
37,670
+445
+1% +$33.1K 1.95% 11
2021
Q1
$2.74M Buy
37,225
+4,079
+12% +$301K 1.96% 13
2020
Q4
$2.59M Sell
33,146
-315
-0.9% -$24.1K 1.88% 14
2020
Q3
$2.65M Buy
33,461
+58
+0.2% +$4.54K 2.17% 10
2020
Q2
$2.46M Buy
33,403
+18
+0.1% +$1.35K 2.21% 10
2020
Q1
$2.45M Buy
33,385
+1,907
+6% +$150K 2.46% 9
2019
Q4
$2.73M Buy
31,478
+341
+1% +$28K 2.08% 12
2019
Q3
$2.5M Sell
31,137
-89
-0.3% -$7.13K 1.97% 13
2019
Q2
$2.5M Buy
31,226
+283
+0.9% +$21.7K 1.97% 10
2019
Q1
$2.46M Sell
30,943
-1,194
-4% -$89.3K 1.96% 9
2018
Q4
$2.34M Buy
32,137
+189
+0.6% +$13.3K 2.13% 10
2018
Q3
$2.16M Buy
31,948
+4,228
+15% +$269K 1.73% 14
2018
Q2
$1.61M Buy
27,720
+6,330
+30% +$357K 1.39% 22
2018
Q1
$1.11M Hold
21,390
0.97% 37
2017
Q4
$1.15M Buy
+21,390
New +$1.19M 0.94% 33

Other funds holding MRK

Pratt Collard Advisory Partners's MRK Position: Q2 2021 in Review

Pratt Collard Advisory Partners increased its Merck (MRK) stake by 1.2% in Q2 2021, buying an estimated $33.1K and bringing the position to 37,670 shares worth $2.93M. The position accounts for 1.95% of the portfolio, ranked #11.

Pratt Collard Advisory Partners first reported a position in MRK in Q4 2017 and has held it in 15 quarters since. 2,674 funds tracked by Wall St. Rank hold MRK as of Q2 2021.

  • Pratt Collard Advisory Partners held 37,670 shares of Merck worth $2.93M as of Q2 2021.
  • Pratt Collard Advisory Partners bought 445 Merck shares in Q2 2021, an estimated $33.1K.
  • Merck made up 1.95% of Pratt Collard Advisory Partners's portfolio in Q2 2021, its #11 holding.
  • Pratt Collard Advisory Partners first reported a position in Merck in Q4 2017 and has held it in 15 quarters since.
  • 2,674 funds tracked by Wall St. Rank held Merck as of Q2 2021.

Based on Pratt Collard Advisory Partners's 13F filing for Q2 2021, filed 14 Jul 2021.